About Metanexgen
Metanexgen is a Healthcare company based in Bensalem (United States) founded in 2000, and was acquired by Insignia Capital Group in April 2015. Multichannel marketing solutions are delivered to pharmaceutical companies by Metanexgen. It operates in the Healthcare and Technology sectors. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Sales & Marketing and Life Sciences. Its competitors include IMS Health, Axtria and Evariant; 2 of its 3 listed competitors have raised funding.
Company details
Metanexgen was established in 2000 through the merger of Meta and NexGen in Bensalem, United States. Digital marketing platforms are provided by the company to pharmaceutical firms for content delivery to healthcare providers and internal sales teams. Targeted, data-driven promotional services are offered across multiple channels within the pharmaceutical sector. Operations focus on technology-enabled communications to support audience engagement.
- Headquarters Bensalem, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Website metanexgen.com
- Social LinkedIn X Facebook
- Acquired by Insignia Capital Group (Apr 2015)
- Latest Funding Round$7.5M (USD), Debt – Venture
Jul 2013
- InvestorsPraesidian Capital
& 1 more
- Acquired byInsignia Capital Group
(Apr 2015)
Funding Insights of Metanexgen
- Total Rounds 2
- Last Round Debt – Venture — $7.5M
- First Round $6M
(Sep 2010)
- Investors Count 1
All 2 funding rounds of Metanexgen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2013 | $7.5M | Debt – Venture | – | – | |
| Sep 2010 | $6M | Debt – Venture | – | – |
2 investors in total: 2 institutional.
Investors in Metanexgen
Metanexgen has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Praesidian Capital and Insignia Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Praesidian Capital is focused on private equity investments in lower middle market businesses. | 2002 | praesidian.com | Oklahoma City, United States | |
Insignia Capital Group is focused on private equity investments. | insigniacap.com |
Investor details for Metanexgen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Metanexgen
4 dated milestones of Metanexgen across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Metanexgen is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Debt – Venture, of $7.5M.
- Exit Acquired by Insignia Capital Group.
Competitors of Metanexgen
Metanexgen has 3 listed competitors in our database, 2 of them funded. They include IMS Health, Axtria and Evariant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imshealth.com | 1954 | Danbury, United States | 17,574 | SaaS and AI-based market intelligence is provided for healthcare companies. | ||
| axtria.com | 2009 | Berkeley Heights, United States | $198.74M | 749 | Data analytics and AI solutions are provided for life sciences. | |
| evariant.com | 2008 | Farmington, United States | $98.83M | 163 | Provides platform for digital marketing solutions |
Detailed competitors of Metanexgen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Metanexgen (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Metanexgen
Complete news archive for Metanexgen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metanexgen
Metanexgen was founded in 2000 and raised its 1st funding round 10 years after it was founded.
Metanexgen is headquartered in Bensalem, United States. It is registered at Bensalem, Pennsylvania, United States.
Metanexgen was established in 2000 through the merger of Meta and NexGen in Bensalem, United States. Digital marketing platforms are provided by the company to pharmaceutical firms for content delivery to healthcare providers and internal sales teams. Targeted, data-driven promotional services are offered across multiple channels within the pharmaceutical sector. Operations focus on technology-enabled communications to support audience engagement.
Metanexgen's top competitors include Axtria, IMS Health and Evariant.
Metanexgen has 2 investors. Key investors include Praesidian Capital, and Insignia Capital Group.
Yes. Metanexgen was acquired by Insignia Capital Group in April 2015.